World Orphan Drug Congress 2017にて講演いたしました

2017.04.21 23:42

World Orphan Drug Congress 2017にて、弊法人西村由希子理事長が講演いたしました。


Making rare and intractable diseases an Asian health priority

  • Japanese ‘Specified Disease Treatment Research Program’ and Orphan drug legislation to encourage orphan drug research 
  • J-Rare and ODOD (Open Discussion for Orphan Drug Discovery programs) to foster
    rare disease identification, registries and diagnosis
  • Connecting Asian rare disease stakeholders to accelerate the path to treatment

Yukiko Nishimura, President, ASrid